Compare FOLD & KMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOLD | KMT |
|---|---|---|
| Founded | 2002 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2007 | N/A |
| Metric | FOLD | KMT |
|---|---|---|
| Price | $9.92 | $27.89 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 6 |
| Target Price | ★ $30.29 | $25.83 |
| AVG Volume (30 Days) | ★ 4.6M | 829.0K |
| Earning Date | 11-04-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 2.85% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.22 |
| Revenue | $598,704,000.00 | ★ $1,982,871,000.00 |
| Revenue This Year | $21.12 | $2.40 |
| Revenue Next Year | $21.23 | $3.62 |
| P/E Ratio | ★ N/A | $23.01 |
| Revenue Growth | ★ 21.28 | N/A |
| 52 Week Low | $5.51 | $17.30 |
| 52 Week High | $10.57 | $28.76 |
| Indicator | FOLD | KMT |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 68.96 |
| Support Level | $9.56 | $27.20 |
| Resistance Level | $10.05 | $28.25 |
| Average True Range (ATR) | 0.37 | 0.71 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 51.14 | 87.91 |
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.